High Implementation Adherence to Lenalidomide in Patients with Multiple Myeloma

被引：0
|
作者：
Leader, Avi [1 ,2 ]
Magen, Hila [1 ,3 ]
Amitai, Irina [1 ,4 ]
Pironet, Antoine [5 ]
Tousset, Eric [5 ]
Rozental, Alon [1 ,2 ]
De Geest, Sabina [6 ,7 ]
Vaxman, Iuliana [1 ,2 ]
Raanani, Pia [1 ,2 ]
Nagler, Arnon [1 ,8 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[2] Rabin Med Ctr, Davidoff Canc Ctr, Inst Hematol, Petah Tiqwa, Israel
[3] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Div Hematol, Ramat Gan, Israel
[5] AARDEX Grp, Liege, Belgium
[6] Univ Basel, Inst Nursing Sci, Dept Publ Hlth, Basel, Switzerland
[7] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Acad Ctr Nursing & Midwifery, Leuven, Belgium
[8] Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplant Unit, Tel Hashomer, Israel
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8068 / 8069
页数：2
相关论文
共 50 条
  • [1] A pilot study of adherence to lenalidomide among older patients with multiple myeloma
    Silberstein, Alice E.
    Fiala, Mark A.
    Loh, Kah Poh
    Cordner, Theresa
    Mian, Hira
    Wildes, Tanya M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (07)
  • [2] Factors associated with non-adherence to lenalidomide in patients with multiple myeloma.
    Leng, Siyang
    Lentzsch, Suzanne
    Chen, Yizhen
    Accordino, Melissa Kate
    Wright, Jason Dennis
    Neugut, Alfred I.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis
    Wildes, Tanya
    Fiala, Mark A.
    Vij, Ravi
    BLOOD, 2017, 130
  • [4] Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02): : 98 - +
  • [5] Pharmacokinetic and bioequivalence of lenalidomide in multiple myeloma patients
    Shen, Qi
    Gao, Tiantao
    Xiang, Jin
    Feng, Ping
    Liu, Xinghong
    Zheng, Li
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (04) : 181 - 188
  • [6] Update on the role of lenalidomide in patients with multiple myeloma
    Holstein, Sarah A.
    Suman, Vera J.
    McCarthy, Philip L.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 175 - 190
  • [7] Lenalidomide Maintenance Therapy in Patients with Multiple Myeloma
    Fillitz, M.
    Seebacher, A.
    Reisner, R.
    Pittermann-Hocker, E.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S90 - S90
  • [8] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Beatriz Guglieri-López
    Alejandro Pérez-Pitarch
    Dirk Jan A. R. Moes
    Begoña Porta-Oltra
    Mónica Climente-Martí
    Henk Jan Guchelaar
    Matilde Merino-Sanjuán
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 189 - 200
  • [9] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Guglieri-Lopez, Beatriz
    Perez-Pitarch, Alejandro
    Moes, Dirk Jan A. R.
    Porta-Oltra, Begona
    Climente-Marti, Monica
    Guchelaar, Henk Jan
    Merino-Sanjuan, Matilde
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 189 - 200
  • [10] Lenalidomide for Multiple Myeloma
    Bertolini, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06): : 573 - 573
12345